Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Enochian Biosciences, Inc. - Common Stock
(NQ:
ENOB
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 4, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Enochian Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Bronstein, Gewirtz & Grossman, LLC Notifies Enochian Biosciences Inc. (ENOB) Investors of Class Action and Encourages Investors to Contact the Firm
August 03, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Enochian Biosciences, Inc. (ENOB) Investors
August 02, 2022
From
Law Offices of Frank R. Cruz
Via
Business Wire
INVESTOR NOTICE: Enochian Biosciences Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ENOB
August 02, 2022
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
Enochian Biosciences Inc. Shareholder Update: Robbins LLP Reminds Investors of Class Action Against Enochian Biosciences Inc. (ENOB)
August 01, 2022
From
Robbins LLP
Via
Business Wire
ENOB CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Enochian Biosciences, Inc.
August 01, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Enochian Biosciences, Inc. (ENOB)
August 01, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the Firm
August 01, 2022
From
The Schall Law Firm
Via
Business Wire
ENOB SHAREHOLDER ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Enochian BioSciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ENOB
July 31, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
SHAREHOLDER ACTON ALERT: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the Firm
July 29, 2022
From
The Schall Law Firm
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Enochian Biosciences, Inc. (ENOB) Investors
July 29, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
ENOB CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Enochian Biosciences, Inc.
July 28, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
EQUITY ALERT: Rosen Law Firm Encourages Enochian BioSciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ENOB
July 28, 2022
From
The Rosen Law Firm, P.A.
Via
Business Wire
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Enochian Biosciences Inc. (ENOB)
July 28, 2022
From
Robbins LLP
Via
Business Wire
ENOCHIAN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Enochian Biosciences, Inc. and Encourages Investors to Contact the Firm
July 27, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
INVESTOR ALERT: Enochian Biosciences Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ENOB
July 27, 2022
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
INVESTOR ACTON ALERT: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the Firm
July 27, 2022
From
The Schall Law Firm
Via
Business Wire
SHAREHOLDER ACTON NOTICE: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the Firm
July 26, 2022
From
The Schall Law Firm
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 18, 2022
Via
Benzinga
Boeing And 24 Stocks Moving Premarket
July 18, 2022
Gainers Qudian Inc. (NYSE: QD) rose 61.3% to $1.92 in pre-market trading after the company issued an update on its QD Food ready-to-cook meal business.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 07, 2022
Via
Benzinga
Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Enochian Biosciences, Inc. (ENOB)
July 07, 2022
From
Kirby McInerney LLP
Via
Business Wire
This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday
July 08, 2022
Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.
Via
Benzinga
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Enochian Biosciences, Inc. (ENOB) on Behalf of Investors
July 06, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Enochian Biosciences, Inc. (ENOB) on Behalf of Investors
July 06, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Continues Investigation of Enochian Biosciences, Inc. (ENOB) on Behalf of Investors
July 05, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 05, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
July 05, 2022
It's time to dive into all of the latest stock market news for Tuesday morning as we go over the biggest pre-market stock movers!
Via
InvestorPlace
Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
July 01, 2022
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase...
Via
Benzinga
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Enochian Biosciences, Inc. (ENOB) on Behalf of Investors
June 28, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Enochian Biosciences, Inc. (ENOB) on Behalf of Investors
June 28, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.